Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1634/theoncologist.2015-0068 http://scihub22266oqcxt.onion/10.1634/theoncologist.2015-0068 C4571792!4571792!25986245     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncologist 2015 ; 20 (6): 572-5 Nephropedia Template TP {{tp|p=25986245|t=2015. Recognizing the Financial Burden of Cancer Patients in Clinical Trials |pdf=|usr=}}{{25986245}} gab.com Text Recognizing the Financial Burden of Cancer Patients in Clinical Trials JO: Oncologist http://www.kidney.de/pget.php?&tw=1&pmid=25986245 #FOAvip Clinical trials often represent an increasingly important option for patients with cancer, thus oncologists participating in clinical research need to consider and address the financial burden associated with trial participation. Future research efforts should focus on developing formal screening tools to identify and monitor for financial burden among clinical trial participants. Twit Text FOAVip Recognizing the Financial Burden of Cancer Patients in Clinical Trials ????Oncologist http://www.kidney.de/pget.php?&tw=1&pmid=25986245 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25986245 #FOAvip English Wikipedia <ref>{{Cite pmid|25986245}}</ref> Recognizing the Financial Burden of Cancer Patients in Clinical Trials #MMPMID25986245 Nipp RD; Powell E; Chabner B; Moy B Oncologist 2015[Jun]; 20 (6): 572-5 PMID25986245show ga Clinical trials often represent an increasingly important option for patients with cancer, thus oncologists participating in clinical research need to consider and address the financial burden associated with trial participation. Future research efforts should focus on developing formal screening tools to identify and monitor for financial burden among clinical trial participants. äRecognizing the Financial Burden of Cancer Patients in Clinical Trials(epmc).pdf DeepDyve Pubget Overpricing